{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T17:51:09Z","timestamp":1776448269743,"version":"3.51.2"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T00:00:00Z","timestamp":1734912000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T00:00:00Z","timestamp":1734912000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA051871"],"award-info":[{"award-number":["R01DA051871"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR001863"],"award-info":[{"award-number":["UL1TR001863"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Addict Sci Clin Pract"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Contingency management (CM), an incentive-based intervention to encourage target behaviors, effectively promotes medication adherence. However, efforts to extend CM to HIV pre-exposure prophylaxis (PrEP) have been lacking. As part of a randomized clinical trial to promote HIV Prevention among people who inject drugs (PWID), we examined the readiness of staff in community-based organizations serving PWID to implement CM for PrEP uptake and adherence in this population.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>From April to August 2022, we conducted a survey of staff from four community-based organizations providing HIV testing, harm reduction, and outreach services in the northeastern United States. We assessed knowledge and attitudes regarding PrEP for PWID on five-point Likert scales (e.g., Poor to Excellent, Not at all to Extremely). Using a modified version of the Contingency Management Beliefs Questionnaire, we assessed the degree to which attitudes about CM for HIV prevention influenced interest in its adoption on a scale from \u201c1-No influence at all\u201d to \u201c5-Very strong influence\u201d. We explored endorsement patterns, along with average values of individual items and subscale scores.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Among 271 staff invitations, 123 (45.4%) responded. The majority (88.6%) of respondents reported prior PrEP awareness, with a mean self-rated knowledge of 2.98 out of 5 (SD\u2009=\u20091.1). Attitudes towards PrEP, including its relevance to and importance for clients (both means\u2009=\u20094.3), efficacy (mean\u2009=\u20094.5), and safety (mean\u2009=\u20094.2), were positive. Items related to practicality and confidence in providing PrEP-related care had relatively lower ratings. Respondents endorsed influential generalized (mean\u2009=\u20092.1) and training-related (mean\u2009=\u20092.5) CM implementation barriers less frequently than positive attitudes towards CM (mean\u2009=\u20093.6). Staff favored adding CM to existing services (mean\u2009=\u20093.8), and highly endorsed it as \u201cuseful for targeting HIV prevention with PrEP\u201d (mean\u2009=\u20093.7).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Respondents generally supported the use of CM to promote HIV prevention among PWID and favored adding it to their existing services. Though respondents understood the value of both PrEP and CM to support HIV prevention activities, findings corroborate research citing relative lack of knowledge and confidence regarding PrEP management among clients, potentially detracting from implementation readiness.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Trial Registration Number<\/jats:title>\n                <jats:p>NCT04738825.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13722-024-00503-4","type":"journal-article","created":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T01:59:01Z","timestamp":1734919141000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Readiness to implement contingency management to promote PrEP initiation and adherence among people who inject drugs: results from a multi-site implementation survey"],"prefix":"10.1186","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4568-1463","authenticated-orcid":false,"given":"Eleanor","family":"Pickering","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Adam","family":"Viera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minhee L.","family":"Sung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Genie","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marianne","family":"Buchelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Kolakowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leah","family":"Maier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E. Jennifer","family":"Edelman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carla J.","family":"Rash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,12,23]]},"reference":[{"key":"503_CR1","doi-asserted-by":"crossref","unstructured":"Strathdee SA, Kuo I, El-Bassel N, Hodder S, Smith LR, Springer SA. Preventing HIV outbreaks among people who inject drugs in the United States: plus \u00e7a change, plus \u00e7a m\u00eame chose. AIDS. 2020;34(14):1997\u20132005.","DOI":"10.1097\/QAD.0000000000002673"},{"issue":"8","key":"503_CR2","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1001\/jama.2023.14461","volume":"330","author":"US Preventive Services Task Force","year":"2023","unstructured":"US Preventive Services Task Force. Preexposure Prophylaxis to Prevent Acquisition of HIV: US Preventive Services Task Force Recommendation Statement. JAMA. 2023;330(8):736\u201345.","journal-title":"JAMA"},{"key":"503_CR3","doi-asserted-by":"publisher","first-page":"108477","DOI":"10.1016\/j.drugalcdep.2020.108477","volume":"219","author":"Z Ni","year":"2021","unstructured":"Ni Z, Altice FL, Wickersham JA, Copenhaver MM, DiDomizio EE, Nelson LE, et al. Willingness to initiate pre-exposure prophylaxis (PrEP) and its use among opioid-dependent individuals in drug treatment. Drug Alcohol Depend. 2021;219:108477.","journal-title":"Drug Alcohol Depend"},{"key":"503_CR4","doi-asserted-by":"publisher","first-page":"215013192110639","DOI":"10.1177\/21501319211063999","volume":"13","author":"B Pleuhs","year":"2022","unstructured":"Pleuhs B, Mistler CB, Quinn KG, Dickson-Gomez J, Walsh JL, Petroll AE, et al. Evidence of potential discriminatory HIV Pre-exposure Prophylaxis (PrEP) prescribing practices for people who inject drugs among a small percentage of providers in the U.S. J Prim Care Community Health. 2022;13:21501319211063999.","journal-title":"J Prim Care Community Health"},{"issue":"5","key":"503_CR5","doi-asserted-by":"publisher","first-page":"1490","DOI":"10.1007\/s10461-020-02988-x","volume":"25","author":"CB Mistler","year":"2021","unstructured":"Mistler CB, Copenhaver MM, Shrestha R. The pre-exposure Prophylaxis (PrEP) Care Cascade in people who inject drugs: a systematic review. AIDS Behav. 2021;25(5):1490\u2013506.","journal-title":"AIDS Behav"},{"issue":"5","key":"503_CR6","doi-asserted-by":"publisher","first-page":"e278","DOI":"10.1097\/ADM.0000000000000973","volume":"16","author":"J Jaiswal","year":"2022","unstructured":"Jaiswal J, Griffin M, Hascher K, Cox AB, Dunlap K, Walters S, et al. Logistical facilitators and barriers to PrEP implementation in Methadone Clinic settings: Provider and Staff perspectives. J Addict Med. 2022;16(5):e278\u201383.","journal-title":"J Addict Med"},{"issue":"4","key":"503_CR7","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1007\/s10461-016-1612-6","volume":"21","author":"EJ Edelman","year":"2017","unstructured":"Edelman EJ, Moore BA, Calabrese SK, Berkenblit G, Cunningham C, Patel V, et al. Primary Care Physicians\u2019 willingness to prescribe HIV pre-exposure Prophylaxis for people who inject drugs. AIDS Behav. 2017;21(4):1025\u201333.","journal-title":"AIDS Behav"},{"issue":"4","key":"503_CR8","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1007\/s11904-021-00556-z","volume":"18","author":"KB Biello","year":"2021","unstructured":"Biello KB, Mimiaga MJ, Valente PK, Saxena N, Bazzi AR. The past, Present, and future of PrEP implementation among people who use drugs. Curr HIV\/AIDS Rep. 2021;18(4):328\u201338.","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"5","key":"503_CR9","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1007\/s11904-022-00615-z","volume":"19","author":"A Andrawis","year":"2022","unstructured":"Andrawis A, Tapa J, Vlaev I, Read D, Schmidtke KA, Chow EPF, Lee D, Fairley CK, Ong JJ. Applying behavioural insights to HIV Prevention and Management: a scoping review. Curr HIV\/AIDS Rep. 2022;19(5):358\u201374. https:\/\/doi.org\/10.1007\/s11904-022-00615-z.","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"Suppl 1","key":"503_CR10","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s10461-019-02554-0","volume":"25","author":"CJ Reback","year":"2021","unstructured":"Reback CJ, Kisler KA, Fletcher JB. A novel adaptation of Peer Health Navigation and Contingency Management for Advancement along the HIV Care Continuum among Transgender women of Color. AIDS Behav. 2021;25(Suppl 1):40\u201351. https:\/\/doi.org\/10.1007\/s10461-019-02554-0.","journal-title":"AIDS Behav"},{"issue":"12","key":"503_CR11","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1097\/QAD.0000000000001543","volume":"31","author":"M Alsan","year":"2017","unstructured":"Alsan M, Beshears J, Armstrong WS, Choi JJ, Madrian BC, Nguyen MLT, Del Rio C, Laibson D, Marconi VC. A commitment contract to achieve virologic suppression in poorly adherent patients with HIV\/AIDS. AIDS. 2017;31(12):1765\u20139. https:\/\/doi.org\/10.1097\/QAD.0000000000001543.","journal-title":"AIDS"},{"issue":"9","key":"503_CR12","doi-asserted-by":"publisher","first-page":"2337","DOI":"10.1007\/s10461-019-02592-8","volume":"23","author":"K Silverman","year":"2019","unstructured":"Silverman K, Holtyn AF, Rodewald AM, Siliciano RF, Jarvis BP, Subramaniam S, Leoutsakos JM, Getty CA, Ruhs S, Marzinke MA, Fingerhood M. Incentives for viral suppression in people living with HIV: a Randomized Clinical Trial. AIDS Behav. 2019;23(9):2337\u201346. https:\/\/doi.org\/10.1007\/s10461-019-02592-8.","journal-title":"AIDS Behav"},{"issue":"6","key":"503_CR13","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1177\/10901981221148966","volume":"50","author":"A Ribeiro","year":"2023","unstructured":"Ribeiro A, Pinto DGA, Trevisol AP, Tardelli V, Arcadepani F, Bosso RA, Ribeiro M, Fidalgo TM. Can Contingency Management solve the problem of adherence to antiretroviral therapy in drug-dependent individuals? Health Educ Behavior: Official Publication Soc Public Health Educ. 2023;50(6):738\u201347. https:\/\/doi.org\/10.1177\/10901981221148966.","journal-title":"Health Educ Behavior: Official Publication Soc Public Health Educ"},{"issue":"1","key":"503_CR14","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13722-017-0081-1","volume":"12","author":"M Stitzer","year":"2017","unstructured":"Stitzer M, Matheson T, Cunningham C, Sorensen JL, Feaster DJ, Gooden L, Hammond AS, Fitzsimons H, Metsch LR. Enhancing patient navigation to improve intervention session attendance and viral load suppression of persons with HIV and substance use: a secondary post hoc analysis of the Project HOPE study. Addict Sci Clin Pract. 2017;12(1):16. https:\/\/doi.org\/10.1186\/s13722-017-0081-1.","journal-title":"Addict Sci Clin Pract"},{"key":"503_CR15","unstructured":"Pfund RA, Ginley MK, Boness CL, Rash CJ, Zajac K, Witkiewitz K. Contingency management for drug use disorders: Meta-analysis and application of Tolin\u2019s criteria. Clinical Psychology: Science and Practice. 2022; Suppl No Pagination Specified-No Pagination Specified."},{"issue":"2","key":"503_CR16","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1111\/j.1360-0443.2006.01311.x","volume":"101","author":"JP Lussier","year":"2006","unstructured":"Lussier JP, Heil SH, Mongeon JA, Badger GJ, Higgins ST. A meta-analysis of voucher-based reinforcement therapy for substance use disorders. Addiction (Abingdon England). 2006;101(2):192\u2013203.","journal-title":"Addiction (Abingdon England)"},{"key":"503_CR17","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.jsat.2016.09.008","volume":"72","author":"CJ Rash","year":"2017","unstructured":"Rash CJ, Stitzer M, Weinstock J. Contingency management: new directions and remaining challenges for an evidence-based intervention. J Subst Abuse Treat. 2017;72:10\u20138.","journal-title":"J Subst Abuse Treat"},{"key":"503_CR18","doi-asserted-by":"crossref","unstructured":"Herrmann ES, Matusiewicz AK, Stitzer ML, Higgins ST, Sigmon SC, Heil SH. Contingency management interventions for HIV, Tuberculosis, and Hepatitis Control among individuals with Substance Use disorders: a systematized review. J Subst Abuse Treat. 2017;72:117\u201325.","DOI":"10.1016\/j.jsat.2016.06.009"},{"issue":"10","key":"503_CR19","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1001\/jamapsychiatry.2021.1969","volume":"78","author":"HA Bol\u00edvar","year":"2021","unstructured":"Bol\u00edvar HA, Klemperer EM, Coleman SRM, DeSarno M, Skelly JM, Higgins ST. Contingency management for patients receiving medication for opioid use disorder: a systematic review and Meta-analysis. JAMA Psychiatry. 2021;78(10):1092\u2013102.","journal-title":"JAMA Psychiatry"},{"issue":"2","key":"503_CR20","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1037\/tps0000245","volume":"7","author":"K Scott","year":"2021","unstructured":"Scott K, Murphy CM, Yap K, Moul S, Hurley L, Becker SJ. Health Professional Stigma as a barrier to Contingency Management Implementation in Opioid Treatment Programs. Translational Issues Psychol Sci. 2021;7(2):166\u201376.","journal-title":"Translational Issues Psychol Sci"},{"issue":"8","key":"503_CR21","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1037\/adb0000287","volume":"31","author":"NM Petry","year":"2017","unstructured":"Petry NM, Alessi SM, Olmstead TA, Rash CJ, Zajac K. Contingency management treatment for substance use disorders: how far has it come, and where does it need to go? Psychol Addict Behav. 2017;31(8):897\u2013906.","journal-title":"Psychol Addict Behav"},{"key":"503_CR22","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.jsat.2016.08.018","volume":"72","author":"M Stitzer","year":"2017","unstructured":"Stitzer M, Calsyn D, Matheson T, Sorensen J, Gooden L, Metsch L. Development of a Multi-target Contingency Management Intervention for HIV positive substance users. J Subst Abuse Treat. 2017;72:66\u201371.","journal-title":"J Subst Abuse Treat"},{"key":"503_CR23","doi-asserted-by":"crossref","unstructured":"Klemperer EM, Evans EA, Rawson R. A call to action: contingency management to improve post-release treatment engagement among people with opioid use disorder who are incarcerated. Prev Med. 2023;107647.","DOI":"10.1016\/j.ypmed.2023.107647"},{"issue":"1","key":"503_CR24","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s12889-018-6314-8","volume":"19","author":"AR Bazzi","year":"2019","unstructured":"Bazzi AR, Drainoni ML, Biancarelli DL, Hartman JJ, Mimiaga MJ, Mayer KH, Biello KB. Systematic review of HIV treatment adherence research among people who inject drugs in the United States and Canada: evidence to inform pre-exposure prophylaxis (PrEP) adherence interventions. BMC Public Health. 2019;19(1):31. https:\/\/doi.org\/10.1186\/s12889-018-6314-8.","journal-title":"BMC Public Health"},{"key":"503_CR25","doi-asserted-by":"publisher","unstructured":"Felsher M, Ziegler E, Amico KR, Carrico A, Coleman J, Roth AM. (2021). PrEP just isn\u2019t my priority: Adherence challenges among women who inject drugs participating in a pre-exposure prophylaxis (PrEP) demonstration project in Philadelphia, PA USA. Social science & medicine (1982), 275, 113809. https:\/\/doi.org\/10.1016\/j.socscimed.2021.113809","DOI":"10.1016\/j.socscimed.2021.113809"},{"key":"503_CR26","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1007\/s10461-016-1612-6","volume":"21","author":"EJ Edelman","year":"2017","unstructured":"Edelman EJ, Moore BA, Calabrese SK, Berkenblit G, Cunningham C, Patel V, Phillips K, Tetrault JM, Shah M, Fiellin DA, Blackstock O. Primary care Physicians\u2019 willingness to prescribe HIV pre-exposure prophylaxis for people who inject drugs. AIDS Behav. 2017;21:1025\u201333.","journal-title":"AIDS Behav"},{"key":"503_CR27","doi-asserted-by":"crossref","unstructured":"Adams LM, Balderson BH. (2016). HIV providers\u2019 likelihood to prescribe pre-exposure prophylaxis (PrEP) for HIV prevention differs by patient type: A short report. AIDS Care. 2016;28(9):1154\u20131158.","DOI":"10.1080\/09540121.2016.1153595"},{"key":"503_CR28","doi-asserted-by":"crossref","unstructured":"Shrestha R, Karki P, Altice FL, Huedo-Medina TB, Meyer JP, Madden L, Copenhaver M. (2017). Correlates of willingness to initiate pre-exposure prophylaxis and anticipation of practicing safer drug- and sex-related behaviors among high-risk drug users on methadone treatment. Drug Alcohol Depend. 2017;173:107\u2013116.","DOI":"10.1016\/j.drugalcdep.2016.12.023"},{"issue":"3","key":"503_CR29","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1097\/MLR.0b013e3182408812","volume":"50","author":"GM Curran","year":"2012","unstructured":"Curran GM, Bauer M, Mittman B, Pyne JM, Stetler C. Effectiveness-implementation hybrid designs: combining elements of clinical effectiveness and implementation research to enhance public health impact. Med Care. 2012;50(3):217\u201326. https:\/\/doi.org\/10.1097\/MLR.0b013e3182408812.","journal-title":"Med Care"},{"key":"503_CR30","doi-asserted-by":"publisher","first-page":"107037","DOI":"10.1016\/j.cct.2022.107037","volume":"125","author":"ML Sung","year":"2023","unstructured":"Sung ML, Viera A, Esserman D, Tong G, Davidson D, Aiudi S, et al. Contingency Management and Pre-exposure Prophylaxis Adherence Support services (CoMPASS): a hybrid type 1 effectiveness-implementation study to promote HIV risk reduction among people who inject drugs. Contemp Clin Trials. 2023;125:107037.","journal-title":"Contemp Clin Trials"},{"issue":"1","key":"503_CR31","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1007\/s11606-016-3903-z","volume":"32","author":"OJ Blackstock","year":"2016","unstructured":"Blackstock OJ, Moore BA, Berkenblit GV, Calabrese SK, Cunningham CO, Fiellin DA, Patel VV, Phillips KA, Tetrault JM, Shah M, Edelman EJ. A cross-sectional online survey of HIV pre-exposure prophylaxis adoption among primary care physicians. J Gen Intern Med. 2016;32(1):62\u201370.","journal-title":"J Gen Intern Med"},{"issue":"3","key":"503_CR32","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.drugalcdep.2011.08.027","volume":"121","author":"CJ Rash","year":"2012","unstructured":"Rash CJ, Petry NM, Kirby KC, Martino S, Roll J, Stitzer ML. Identifying provider beliefs related to contingency management adoption using the contingency management beliefs questionnaire. Drug Alcohol Depend. 2012;121(3):205\u201312.","journal-title":"Drug Alcohol Depend"},{"key":"503_CR33","doi-asserted-by":"publisher","first-page":"103208","DOI":"10.1016\/j.jbi.2019.103208","volume":"95","author":"PA Harris","year":"2019","unstructured":"Harris PA, Taylor R, Minor BL, Elliott V, Fernandez M, O\u2019Neal L, et al. The REDCap consortium: building an international community of software platform partners. J Biomed Inform. 2019;95:103208.","journal-title":"J Biomed Inform"},{"issue":"2","key":"503_CR34","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","volume":"42","author":"PA Harris","year":"2009","unstructured":"Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)\u2014A metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42(2):377\u201381.","journal-title":"J Biomed Inform"},{"issue":"1","key":"503_CR35","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1186\/s12913-023-09878-7","volume":"23","author":"O Oluwoye","year":"2023","unstructured":"Oluwoye O, Weeks DL, McDonell MG. An unexplored equity factor: differential beliefs and attitudes toward contingency management by providers\u2019 ethnicity. BMC Health Serv Res. 2023;23(1):902.","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"503_CR36","doi-asserted-by":"publisher","first-page":"89","DOI":"10.15288\/jsad.22-00036","volume":"84","author":"ME Cowie","year":"2023","unstructured":"Cowie ME, Hodgins DC. Contingency Management in Canadian addiction treatment: provider attitudes and use. J Stud Alcohol Drug. 2023;84(1):89\u201396.","journal-title":"J Stud Alcohol Drug"},{"issue":"3","key":"503_CR37","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.jsat.2013.03.003","volume":"45","author":"CJ Rash","year":"2013","unstructured":"Rash CJ, DePhilippis D, McKay JR, Drapkin M, Petry NM. Training workshops positively impact beliefs about contingency management in a nationwide dissemination effort. J Subst Abuse Treat. 2013;45(3):306\u201312.","journal-title":"J Subst Abuse Treat"},{"key":"503_CR38","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.jsat.2018.07.009","volume":"94","author":"SG Mitchell","year":"2018","unstructured":"Mitchell SG, Monico LB, Stitzer M, Matheson T, Sorensen JL, Feaster DJ, et al. How patient navigators view the use of financial incentives to influence study involvement, substance use, and HIV treatment. J Subst Abuse Treat. 2018;94:18\u201323.","journal-title":"J Subst Abuse Treat"},{"issue":"1","key":"503_CR39","first-page":"83","volume":"29","author":"L Turner","year":"2018","unstructured":"Turner L, Roepke A, Wardell E, Teitelman AM. Do you PrEP? A review of primary care provider knowledge of PrEP and attitudes on prescribing PrEP. JANAC. 2018;29(1):83\u201392.","journal-title":"JANAC"},{"key":"503_CR40","doi-asserted-by":"publisher","first-page":"108371","DOI":"10.1016\/j.jsat.2021.108371","volume":"129","author":"J Jaiswal","year":"2021","unstructured":"Jaiswal J, Dunlap K, Griffin M, Cox A, Singer SN, Hascher K, LoSchiavo C, Walters SM, Mumba M. Pre-exposure prophylaxis awareness, acceptability and potential stigma among medical and non-medical clinic staff in methadone treatment settings in northern New Jersey: the key role of non-medical staff in enhancing HIV prevention. J Subst Abuse Treat. 2021;129:108371.","journal-title":"J Subst Abuse Treat"},{"key":"503_CR41","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1111\/hiv.12285","volume":"17","author":"M Desai","year":"2016","unstructured":"Desai M, Gafos M, Dolling D, McCormack S, Nardone A. PROUD study Healthcare providers\u2019 knowledge of, attitudes to and practice of pre-exposure prophylaxis for HIV infection. HIV Med. 2016;17:133\u201342. https:\/\/doi.org\/10.1111\/hiv.12285.","journal-title":"HIV Med"},{"issue":"5","key":"503_CR42","doi-asserted-by":"publisher","first-page":"1256","DOI":"10.1007\/s10461-016-1625-1","volume":"21","author":"AE Petroll","year":"2017","unstructured":"Petroll AE, Walsh JL, Owczarzak JL, McAuliffe TL, Bogart LM, Kelly JA. PrEP awareness, Familiarity, Comfort, and prescribing experience among US Primary Care providers and HIV specialists. AIDS Behav. 2017;21(5):1256\u201367.","journal-title":"AIDS Behav"},{"issue":"7","key":"503_CR43","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1097\/OLQ.0000000000000781","volume":"45","author":"BR Wood","year":"2018","unstructured":"Wood BR, McMahan VM, Naismith K, Stockton JB, Delaney LA, Stekler JD. Knowledge, practices, and barriers to HIV Preexposure Prophylaxis Prescribing among Washington State Medical Providers. Sex Transm Dis. 2018;45(7):452\u20138.","journal-title":"Sex Transm Dis"},{"key":"503_CR44","doi-asserted-by":"publisher","first-page":"215013192211472","DOI":"10.1177\/21501319221147254","volume":"14","author":"J Sell","year":"2023","unstructured":"Sell J, Chen R, Huber C, Parascando J, Nunez J. Primary care provider HIV PrEP Knowledge, attitudes, and Prescribing habits: a cross-sectional survey of late adopters in rural and suburban practice. J Prim care Community Health. 2023;14:21501319221147254.","journal-title":"J Prim care Community Health"},{"issue":"3","key":"503_CR45","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1097\/ADM.0000000000000729","volume":"15","author":"AJ Kennedy","year":"2021","unstructured":"Kennedy AJ, Hassan I, Cameron FA, Gobao V, Edelman EJ, Ho K, Fisk S, Hamm M, Merlin JS. Barriers and facilitators to providing HIV Preexposure Prophylaxis among Buprenorphine prescribers: a pilot qualitative study. J Addict Med. 2021;15(3):261\u20133.","journal-title":"J Addict Med"},{"issue":"4","key":"503_CR46","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1007\/s11606-022-07672-5","volume":"38","author":"AR Bazzi","year":"2023","unstructured":"Bazzi AR, Shaw LC, Biello KB, Vahey S, Brody JK. Patient and provider perspectives on a Novel, low-threshold HIV PrEP Program for people who inject drugs experiencing homelessness. J Gen Intern Med. 2023;38(4):913\u201321.","journal-title":"J Gen Intern Med"}],"container-title":["Addiction Science &amp; Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13722-024-00503-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13722-024-00503-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13722-024-00503-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,23]],"date-time":"2024-12-23T02:05:30Z","timestamp":1734919530000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascpjournal.biomedcentral.com\/articles\/10.1186\/s13722-024-00503-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,23]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["503"],"URL":"https:\/\/doi.org\/10.1186\/s13722-024-00503-4","relation":{},"ISSN":["1940-0640"],"issn-type":[{"value":"1940-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,23]]},"assertion":[{"value":"13 December 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"These research activities have been approved by institutional review boards at Yale University, as well as Connecticut and Massachusetts Departments of Health. These Departments of Public Health do not endorse or assume any responsibility for any analyses, interpretations, or conclusions based on these data. The authors assume full responsibility for all such analyses, interpretations, and conclusions.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"97"}}